ClinicalTrials.Veeva

Menu

Single-arm Study of LDART for Stimulant Use Disorder

Yale University logo

Yale University

Status

Begins enrollment this month

Conditions

Methamphetamine Use Disorder
Stimulant Use Disorder
Cocaine Use Disorder

Treatments

Behavioral: LDART

Study type

Interventional

Funder types

Other

Identifiers

NCT07221396
2000040872
EarlyCareer Investigator grant (Other Grant/Funding Number)

Details and patient eligibility

About

The goal of this study is to evaluate the feasibility, acceptability, and preliminary efficacy of a digital intervention called LDART in adults with stimulant use disorder.

Enrollment

40 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 years of age or older
  • Currently reside in Connecticut, USA
  • Have a smartphone that can send and receive text messages and have internet access that can be access over the course of a month
  • Substance (Stimulant) Use Symptom Checklist ≥2, indicating past-year stimulant use disorder
  • Had high frequency of cocaine use (≥5 days) in the past 28 days
  • Have some self-reported desire to cut down or quit stimulants

Exclusion criteria

  • Unable to provide informed consent, as assessed by the consent quiz
  • Unable to speak, read, or write in English
  • Vulnerable population status
  • Unlikely to be able to complete study procedures in the next 2-3 months

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

40 participants in 1 patient group

LDART
Experimental group
Description:
Participants will be given access to LDART for 28 days.
Treatment:
Behavioral: LDART

Trial contacts and locations

1

Loading...

Central trial contact

Li Yan McCurdy, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems